Relation Therapeutics secures $35 million of new seed financing
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
LONDON--(BUSINESS WIRE)--Relation Therapeutics, the pioneer of drug discovery using active-graph machine learning (ML) combined with single-cell analysis and deep clinical insights, announced today that it had raised a $25 million investment and hired a Chief Executive Officer and Chief Technology Officer. The funding and expanded leadership will enable Relation to scale its platform and advance therapeutic candidates for diseases with no or few good medicines.